Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The integration of artificial intelligence (AI) into the healthcare sector is accelerating at an unprecedented...
AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.
Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Experts predict that artificial intelligence (AI) will soon transition from a novel concept in healthcare...
As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.
A few enterprising businesses are marketing themselves differently.
Morgan Stanley is betting on these stocks to benefit from the AI megatrend.
AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.
The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven...
2024 is going to be a sizzler in the biopharma sector.
Its groundbreaking work is winning it some powerful fans, but it's still risky.